APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Custom Adeno-Associated Virus (AAV) Services

Compare research editions
View pricing & licenses

Selected research

Industry Research

Custom Adeno-Associated Virus (AAV) Services Industry Research Report 2026

Report ID 17410794052 May 2026141 pages

Choose your research edition.

Industry ResearchCustom Adeno-Associated Virus (AAV) Services Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Adeno-Associated Virus (AAV) Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Custom Adeno-Associated Virus (AAV) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Adeno-Associated Virus (AAV) Services Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Adeno-Associated Virus (AAV) Services Market Analysis and Forecast 2026-2032225 pages · $4,950 USD

Market perspective

The global Custom Adeno-Associated Virus (AAV) Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Custom Adeno-Associated Virus (AAV) Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Adeno-Associated Virus (AAV) Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Adeno-Associated Virus (AAV) Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Adeno-Associated Virus (AAV) Services include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed） and Gene Universal, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Custom Adeno-Associated Virus (AAV) Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Adeno-Associated Virus (AAV) Services.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Custom Adeno-Associated Virus (AAV) Services Market by Company

Thermo Fisher Scientific

Lonza

Catalent

Charles River

Merck

SK pharmteco

Oxford Biomedica

AGC Biologics（MolMed）

Gene Universal

Polyplus (Sartorius)

CCRM

FUJIFILM Diosynth Biotechnologies

Biovian

Miltenyi Bioindustry

Aldevron

Takara Bio

Yposkesi

Genezen

Exthera

GenScript ProBio

EurekaBio

Obio Technology

GeneSail Biotech

VectorBuilder

WuXi ATU

Ubrigene

Porton Biologics

Pharmaron

PackGene Biotechnology

Custom Adeno-Associated Virus (AAV) Services Segment by Type

Adherent Culture

Suspension Culture

Custom Adeno-Associated Virus (AAV) Services Segment by Application

Vaccine Development

Gene Therapy

Academic Scientific Research Institution

Others

Custom Adeno-Associated Virus (AAV) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Adeno-Associated Virus (AAV) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Adeno-Associated Virus (AAV) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Adeno-Associated Virus (AAV) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Custom Adeno-Associated Virus (AAV) Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Type (2021-2026) Table 7. Global Custom Adeno-Associated Virus (AAV) Services Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Type (2027-2032) Table 9. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Application (2021-2026) Table 11. Global Custom Adeno-Associated Virus (AAV) Services Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Application (2027-2032) Table 13. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region (2021-2026) Table 16. Global Custom Adeno-Associated Virus (AAV) Services Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region (2027-2032) Table 18. Custom Adeno-Associated Virus (AAV) Services Industry Trends Table 19. Custom Adeno-Associated Virus (AAV) Services Industry Drivers Table 20. Custom Adeno-Associated Virus (AAV) Services Industry Opportunities and Challenges Table 21. Custom Adeno-Associated Virus (AAV) Services Market Restraints Table 22. Global Top Custom Adeno-Associated Virus (AAV) Services Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Players (2021-2026) Table 24. Global Custom Adeno-Associated Virus (AAV) Services Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Custom Adeno-Associated Virus (AAV) Services, Headquarters and Area Served Table 26. Global Custom Adeno-Associated Virus (AAV) Services Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Custom Adeno-Associated Virus (AAV) Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032) & (US$ Million) Table 45. Thermo Fisher Scientific Company Information Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 48. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 49. Thermo Fisher Scientific Recent Developments Table 50. Lonza Company Information Table 51. Lonza Business Overview Table 52. Lonza Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 53. Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 54. Lonza Recent Developments Table 55. Catalent Company Information Table 56. Catalent Business Overview Table 57. Catalent Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 58. Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 59. Catalent Recent Developments Table 60. Charles River Company Information Table 61. Charles River Business Overview Table 62. Charles River Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 63. Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 64. Charles River Recent Developments Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 68. Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 69. Merck Recent Developments Table 70. SK pharmteco Company Information Table 71. SK pharmteco Business Overview Table 72. SK pharmteco Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 73. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 74. SK pharmteco Recent Developments Table 75. Oxford Biomedica Company Information Table 76. Oxford Biomedica Business Overview Table 77. Oxford Biomedica Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 78. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 79. Oxford Biomedica Recent Developments Table 80. AGC Biologics（MolMed） Company Information Table 81. AGC Biologics（MolMed） Business Overview Table 82. AGC Biologics（MolMed） Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 83. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 84. AGC Biologics（MolMed） Recent Developments Table 85. Gene Universal Company Information Table 86. Gene Universal Business Overview Table 87. Gene Universal Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 88. Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 89. Gene Universal Recent Developments Table 90. Polyplus (Sartorius) Company Information Table 91. Polyplus (Sartorius) Business Overview Table 92. Polyplus (Sartorius) Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 93. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 94. Polyplus (Sartorius) Recent Developments Table 95. CCRM Company Information Table 96. CCRM Business Overview Table 97. CCRM Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 98. CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 99. CCRM Recent Developments Table 100. FUJIFILM Diosynth Biotechnologies Company Information Table 101. FUJIFILM Diosynth Biotechnologies Business Overview Table 102. FUJIFILM Diosynth Biotechnologies Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 103. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 104. FUJIFILM Diosynth Biotechnologies Recent Developments Table 105. Biovian Company Information Table 106. Biovian Business Overview Table 107. Biovian Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 108. Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 109. Biovian Recent Developments Table 110. Miltenyi Bioindustry Company Information Table 111. Miltenyi Bioindustry Business Overview Table 112. Miltenyi Bioindustry Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 113. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 114. Miltenyi Bioindustry Recent Developments Table 115. Aldevron Company Information Table 116. Aldevron Business Overview Table 117. Aldevron Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 118. Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 119. Aldevron Recent Developments Table 120. Takara Bio Company Information Table 121. Takara Bio Business Overview Table 122. Takara Bio Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 123. Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 124. Takara Bio Recent Developments Table 125. Yposkesi Company Information Table 126. Yposkesi Business Overview Table 127. Yposkesi Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 128. Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 129. Yposkesi Recent Developments Table 130. Genezen Company Information Table 131. Genezen Business Overview Table 132. Genezen Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 133. Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 134. Genezen Recent Developments Table 135. Exthera Company Information Table 136. Exthera Business Overview Table 137. Exthera Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 138. Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 139. Exthera Recent Developments Table 140. GenScript ProBio Company Information Table 141. GenScript ProBio Business Overview Table 142. GenScript ProBio Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 143. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 144. GenScript ProBio Recent Developments Table 145. EurekaBio Company Information Table 146. EurekaBio Business Overview Table 147. EurekaBio Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 148. EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 149. EurekaBio Recent Developments Table 150. Obio Technology Company Information Table 151. Obio Technology Business Overview Table 152. Obio Technology Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 153. Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 154. Obio Technology Recent Developments Table 155. GeneSail Biotech Company Information Table 156. GeneSail Biotech Business Overview Table 157. GeneSail Biotech Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 158. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 159. GeneSail Biotech Recent Developments Table 160. VectorBuilder Company Information Table 161. VectorBuilder Business Overview Table 162. VectorBuilder Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 163. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 164. VectorBuilder Recent Developments Table 165. WuXi ATU Company Information Table 166. WuXi ATU Business Overview Table 167. WuXi ATU Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 168. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 169. WuXi ATU Recent Developments Table 170. Ubrigene Company Information Table 171. Ubrigene Business Overview Table 172. Ubrigene Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 173. Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 174. Ubrigene Recent Developments Table 175. Porton Biologics Company Information Table 176. Porton Biologics Business Overview Table 177. Porton Biologics Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 178. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 179. Porton Biologics Recent Developments Table 180. Pharmaron Company Information Table 181. Pharmaron Business Overview Table 182. Pharmaron Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 183. Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 184. Pharmaron Recent Developments Table 185. PackGene Biotechnology Company Information Table 186. PackGene Biotechnology Business Overview Table 187. PackGene Biotechnology Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) & (US$ Million) Table 188. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 189. PackGene Biotechnology Recent Developments Table 190. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Custom Adeno-Associated Virus (AAV) Services Product Image Figure 5. Global Custom Adeno-Associated Virus (AAV) Services Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Type: 2025 VS 2032 Figure 7. Adherent Culture Product Figure 8. Suspension Culture Product Figure 9. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Application: 2025 VS 2032 Figure 11. Vaccine Development Product Figure 12. Gene Therapy Product Figure 13. Academic Scientific Research Institution Product Figure 14. Others Product Figure 15. Global Custom Adeno-Associated Virus (AAV) Services Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Custom Adeno-Associated Virus (AAV) Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region: 2025 VS 2032 Figure 18. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Players in 2025 Figure 19. Global Custom Adeno-Associated Virus (AAV) Services Manufacturers Established Date Figure 20. Global Top 5 and 10 Custom Adeno-Associated Virus (AAV) Services Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 24. United States Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 27. Europe Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 29. Germany Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 39. China Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 44. Australia Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 49. Brazil Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Custom Adeno-Associated Virus (AAV) Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 55. Lonza Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 56. Catalent Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 57. Charles River Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 58. Merck Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 59. SK pharmteco Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 60. Oxford Biomedica Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 61. AGC Biologics（MolMed） Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 62. Gene Universal Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 63. Polyplus (Sartorius) Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 64. CCRM Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 65. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 66. Biovian Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 67. Miltenyi Bioindustry Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 68. Aldevron Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 69. Takara Bio Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 70. Yposkesi Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 71. Genezen Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 72. Exthera Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 73. GenScript ProBio Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 74. EurekaBio Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 75. Obio Technology Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 76. GeneSail Biotech Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 77. VectorBuilder Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 78. WuXi ATU Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 79. Ubrigene Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 80. Porton Biologics Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 81. Pharmaron Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026) Figure 82. PackGene Biotechnology Revenue Growth Rate in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)

Scope & coverage.

Types
  • Adherent Culture
  • Suspension Culture
Applications
  • Vaccine Development
  • Gene Therapy
  • Academic Scientific Research Institution
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Lonza
  • Catalent
  • Charles River
  • Merck
  • SK pharmteco
  • Oxford Biomedica
  • AGC Biologics（MolMed）
  • Gene Universal
  • Polyplus (Sartorius)
  • CCRM
  • FUJIFILM Diosynth Biotechnologies
  • Biovian
  • Miltenyi Bioindustry
  • Aldevron
  • Takara Bio
  • Yposkesi
  • Genezen
  • Exthera
  • GenScript ProBio
  • EurekaBio
  • Obio Technology
  • GeneSail Biotech
  • VectorBuilder
  • WuXi ATU
  • Ubrigene
  • Porton Biologics
  • Pharmaron
  • PackGene Biotechnology

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Custom Adeno-Associated Virus (AAV) Services by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Adherent Culture
  5. 2.2.3 Suspension Culture
  6. 2.3 Custom Adeno-Associated Virus (AAV) Services by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Vaccine Development
  9. 2.3.3 Gene Therapy
  10. 2.3.4 Academic Scientific Research Institution
  11. 2.3.5 Others
  12. 2.4 Assumptions and Limitations
3 Custom Adeno-Associated Virus (AAV) Services Breakdown Data by Type
  1. 3.1 Global Custom Adeno-Associated Virus (AAV) Services Historic Market Size by Type (2021-2026)
  2. 3.2 Global Custom Adeno-Associated Virus (AAV) Services Forecasted Market Size by Type (2027-2032)
4 Custom Adeno-Associated Virus (AAV) Services Breakdown Data by Application
  1. 4.1 Global Custom Adeno-Associated Virus (AAV) Services Historic Market Size by Application (2021-2026)
  2. 4.2 Global Custom Adeno-Associated Virus (AAV) Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Custom Adeno-Associated Virus (AAV) Services Market Perspective (2021-2032)
  2. 5.2 Global Custom Adeno-Associated Virus (AAV) Services Growth Trends by Region
  3. 5.2.1 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Custom Adeno-Associated Virus (AAV) Services Historic Market Size by Region (2021-2026)
  5. 5.2.3 Custom Adeno-Associated Virus (AAV) Services Forecasted Market Size by Region (2027-2032)
  6. 5.3 Custom Adeno-Associated Virus (AAV) Services Market Dynamics
  7. 5.3.1 Custom Adeno-Associated Virus (AAV) Services Industry Trends
  8. 5.3.2 Custom Adeno-Associated Virus (AAV) Services Market Drivers
  9. 5.3.3 Custom Adeno-Associated Virus (AAV) Services Market Challenges
  10. 5.3.4 Custom Adeno-Associated Virus (AAV) Services Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Custom Adeno-Associated Virus (AAV) Services Players by Revenue
  2. 6.1.1 Global Top Custom Adeno-Associated Virus (AAV) Services Players by Revenue (2021-2026)
  3. 6.1.2 Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Custom Adeno-Associated Virus (AAV) Services Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Custom Adeno-Associated Virus (AAV) Services Head Office and Area Served
  6. 6.4 Global Custom Adeno-Associated Virus (AAV) Services Players, Product Type & Application
  7. 6.5 Global Custom Adeno-Associated Virus (AAV) Services Manufacturers Established Date
  8. 6.6 Global Custom Adeno-Associated Virus (AAV) Services Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032)
  2. 7.2 North America Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  4. 7.4 North America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032)
  2. 8.2 Europe Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  4. 8.4 Europe Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032)
  2. 9.2 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032)
  2. 10.2 South America Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  4. 10.4 South America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032)
  2. 11.2 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Thermo Fisher Scientific
  2. 12.1.1 Thermo Fisher Scientific Company Information
  3. 12.1.2 Thermo Fisher Scientific Business Overview
  4. 12.1.3 Thermo Fisher Scientific Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  5. 12.1.4 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  6. 12.1.5 Thermo Fisher Scientific Recent Developments
  7. 12.2 Lonza
  8. 12.2.1 Lonza Company Information
  9. 12.2.2 Lonza Business Overview
  10. 12.2.3 Lonza Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  11. 12.2.4 Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  12. 12.2.5 Lonza Recent Developments
  13. 12.3 Catalent
  14. 12.3.1 Catalent Company Information
  15. 12.3.2 Catalent Business Overview
  16. 12.3.3 Catalent Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  17. 12.3.4 Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  18. 12.3.5 Catalent Recent Developments
  19. 12.4 Charles River
  20. 12.4.1 Charles River Company Information
  21. 12.4.2 Charles River Business Overview
  22. 12.4.3 Charles River Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  23. 12.4.4 Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  24. 12.4.5 Charles River Recent Developments
  25. 12.5 Merck
  26. 12.5.1 Merck Company Information
  27. 12.5.2 Merck Business Overview
  28. 12.5.3 Merck Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  29. 12.5.4 Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  30. 12.5.5 Merck Recent Developments
  31. 12.6 SK pharmteco
  32. 12.6.1 SK pharmteco Company Information
  33. 12.6.2 SK pharmteco Business Overview
  34. 12.6.3 SK pharmteco Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  35. 12.6.4 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  36. 12.6.5 SK pharmteco Recent Developments
  37. 12.7 Oxford Biomedica
  38. 12.7.1 Oxford Biomedica Company Information
  39. 12.7.2 Oxford Biomedica Business Overview
  40. 12.7.3 Oxford Biomedica Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  41. 12.7.4 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  42. 12.7.5 Oxford Biomedica Recent Developments
  43. 12.8 AGC Biologics（MolMed）
  44. 12.8.1 AGC Biologics（MolMed） Company Information
  45. 12.8.2 AGC Biologics（MolMed） Business Overview
  46. 12.8.3 AGC Biologics（MolMed） Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  47. 12.8.4 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  48. 12.8.5 AGC Biologics（MolMed） Recent Developments
  49. 12.9 Gene Universal
  50. 12.9.1 Gene Universal Company Information
  51. 12.9.2 Gene Universal Business Overview
  52. 12.9.3 Gene Universal Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  53. 12.9.4 Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  54. 12.9.5 Gene Universal Recent Developments
  55. 12.10 Polyplus (Sartorius)
  56. 12.10.1 Polyplus (Sartorius) Company Information
  57. 12.10.2 Polyplus (Sartorius) Business Overview
  58. 12.10.3 Polyplus (Sartorius) Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  59. 12.10.4 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  60. 12.10.5 Polyplus (Sartorius) Recent Developments
  61. 12.11 CCRM
  62. 12.11.1 CCRM Company Information
  63. 12.11.2 CCRM Business Overview
  64. 12.11.3 CCRM Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  65. 12.11.4 CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  66. 12.11.5 CCRM Recent Developments
  67. 12.12 FUJIFILM Diosynth Biotechnologies
  68. 12.12.1 FUJIFILM Diosynth Biotechnologies Company Information
  69. 12.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
  70. 12.12.3 FUJIFILM Diosynth Biotechnologies Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  71. 12.12.4 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  72. 12.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  73. 12.13 Biovian
  74. 12.13.1 Biovian Company Information
  75. 12.13.2 Biovian Business Overview
  76. 12.13.3 Biovian Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  77. 12.13.4 Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  78. 12.13.5 Biovian Recent Developments
  79. 12.14 Miltenyi Bioindustry
  80. 12.14.1 Miltenyi Bioindustry Company Information
  81. 12.14.2 Miltenyi Bioindustry Business Overview
  82. 12.14.3 Miltenyi Bioindustry Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  83. 12.14.4 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  84. 12.14.5 Miltenyi Bioindustry Recent Developments
  85. 12.15 Aldevron
  86. 12.15.1 Aldevron Company Information
  87. 12.15.2 Aldevron Business Overview
  88. 12.15.3 Aldevron Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  89. 12.15.4 Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  90. 12.15.5 Aldevron Recent Developments
  91. 12.16 Takara Bio
  92. 12.16.1 Takara Bio Company Information
  93. 12.16.2 Takara Bio Business Overview
  94. 12.16.3 Takara Bio Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  95. 12.16.4 Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  96. 12.16.5 Takara Bio Recent Developments
  97. 12.17 Yposkesi
  98. 12.17.1 Yposkesi Company Information
  99. 12.17.2 Yposkesi Business Overview
  100. 12.17.3 Yposkesi Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  101. 12.17.4 Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  102. 12.17.5 Yposkesi Recent Developments
  103. 12.18 Genezen
  104. 12.18.1 Genezen Company Information
  105. 12.18.2 Genezen Business Overview
  106. 12.18.3 Genezen Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  107. 12.18.4 Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  108. 12.18.5 Genezen Recent Developments
  109. 12.19 Exthera
  110. 12.19.1 Exthera Company Information
  111. 12.19.2 Exthera Business Overview
  112. 12.19.3 Exthera Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  113. 12.19.4 Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  114. 12.19.5 Exthera Recent Developments
  115. 12.20 GenScript ProBio
  116. 12.20.1 GenScript ProBio Company Information
  117. 12.20.2 GenScript ProBio Business Overview
  118. 12.20.3 GenScript ProBio Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  119. 12.20.4 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  120. 12.20.5 GenScript ProBio Recent Developments
  121. 12.21 EurekaBio
  122. 12.21.1 EurekaBio Company Information
  123. 12.21.2 EurekaBio Business Overview
  124. 12.21.3 EurekaBio Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  125. 12.21.4 EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  126. 12.21.5 EurekaBio Recent Developments
  127. 12.22 Obio Technology
  128. 12.22.1 Obio Technology Company Information
  129. 12.22.2 Obio Technology Business Overview
  130. 12.22.3 Obio Technology Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  131. 12.22.4 Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  132. 12.22.5 Obio Technology Recent Developments
  133. 12.23 GeneSail Biotech
  134. 12.23.1 GeneSail Biotech Company Information
  135. 12.23.2 GeneSail Biotech Business Overview
  136. 12.23.3 GeneSail Biotech Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  137. 12.23.4 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  138. 12.23.5 GeneSail Biotech Recent Developments
  139. 12.24 VectorBuilder
  140. 12.24.1 VectorBuilder Company Information
  141. 12.24.2 VectorBuilder Business Overview
  142. 12.24.3 VectorBuilder Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  143. 12.24.4 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  144. 12.24.5 VectorBuilder Recent Developments
  145. 12.25 WuXi ATU
  146. 12.25.1 WuXi ATU Company Information
  147. 12.25.2 WuXi ATU Business Overview
  148. 12.25.3 WuXi ATU Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  149. 12.25.4 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  150. 12.25.5 WuXi ATU Recent Developments
  151. 12.26 Ubrigene
  152. 12.26.1 Ubrigene Company Information
  153. 12.26.2 Ubrigene Business Overview
  154. 12.26.3 Ubrigene Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  155. 12.26.4 Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  156. 12.26.5 Ubrigene Recent Developments
  157. 12.27 Porton Biologics
  158. 12.27.1 Porton Biologics Company Information
  159. 12.27.2 Porton Biologics Business Overview
  160. 12.27.3 Porton Biologics Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  161. 12.27.4 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  162. 12.27.5 Porton Biologics Recent Developments
  163. 12.28 Pharmaron
  164. 12.28.1 Pharmaron Company Information
  165. 12.28.2 Pharmaron Business Overview
  166. 12.28.3 Pharmaron Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  167. 12.28.4 Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  168. 12.28.5 Pharmaron Recent Developments
  169. 12.29 PackGene Biotechnology
  170. 12.29.1 PackGene Biotechnology Company Information
  171. 12.29.2 PackGene Biotechnology Business Overview
  172. 12.29.3 PackGene Biotechnology Revenue in Custom Adeno-Associated Virus (AAV) Services Business (2021-2026)
  173. 12.29.4 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  174. 12.29.5 PackGene Biotechnology Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst